Companies
- Companies
- Browse
Companies
Research driven, human biotherapeutics company focused on rDNA products offering out-licensing of biogeneric bulk-API and finished formulations, contract research and contract manufacturing services. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 19 pages - $99
Mar 2009 - 20 pages - $995
Dec 2010 - 27 pages - $995
Aug 2010 - 37 pages - $250
Feb 2010 - 22 pages - $995
Nov 2010 - 19 pages - $99
Sep 2011 - 36 pages - $250
Feb 2010 - 65 pages - $995
Nov 2010 - 26 pages - $125
Nov 2009 - $15,200
Your selection
Browse By
- Therapeutic target
- Anti-oxidant
- Bladder cancer
- Bone cancer
- Brain cancer
- Breast cancer
- Cancer (other)
- Cancer side effects
- Cervical cancer
- Colorectal cancer
- Head and neck cancer
- Kaposi's sarcoma
- Kidney cancer
- Leukemia
- Liver cancer
- Lung cancer
- Lymphoma
- Ovarian cancer
- Pancreatic cancer
- Polyps
- Prostate cancer
- Skin cancer
- Stomach/Esophageal
- Testicular cancer
- Transplant
- Treatments
- Tumor (other)
- Vaginal Cancer
- Womb cancer
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us